Pelareorep Evidence: Trial Results and Peer-Reviewed Publications

Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated:

The clinical evidence base for Pelareorep comprises 1 peer-reviewed publications across 1 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Multiple Myeloma. Most recent publication: Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects., J Hematol Oncol, 2025.

Top peer-reviewed publications

Curated set of pivotal-trial result papers and recent publications in high-tier journals.

  1. Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects.
    Dona AA, Tandoh T, Nigam L, et al. · J Hematol Oncol · 2025
    PubMed: PMID 39828738 · NCT02101944 · Multiple Myeloma

Publications by year

2025–2025: 1 publications.

2025
1

Publications by indication

Multiple Myeloma (1)

  • Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects.
    J Hematol Oncol · 2025 · PMID 39828738 · NCT02101944

Publications by journal

  • J Hematol Oncol1 paper

All Pelareorep publications (1)

2025 (1 paper)

  1. Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects.
    Dona AA, Tandoh T, Nigam L, et al. · J Hematol Oncol · 2025 · Derived
    PubMed: PMID 39828738 · NCT02101944 · Multiple Myeloma

Sources and methodology

  • Publications: ctgov.study_references (PubMed PMIDs auto-attached by ClinicalTrials.gov to each trial), reference types RESULT, DERIVED, and BACKGROUND.
  • Per-arm outcome values: ctgov.outcome_measurements joined to ctgov.design_outcomes where outcome_type = 'PRIMARY', restricted to phase PHASE3 and PHASE2/PHASE3.
  • Publication metadata (title, journal, year, authors): PubMed E-utilities efetch.fcgi
  • Data freshness: Thu, 14 May 2026 22:10:22 GMT.
This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).